CX3CR1 is also a major receptor for respiratory syncytial virus infections and has been found to modulate airway inflammation and mucus production (Das et al., 2017), as well as LPS-induced lung injury through NFκB activation (Ding et al., 2016). The gene discussed is CX3CR1; the disease is respiratory syncytial virus infectious disease.